scout
|Videos|July 7, 2020

Expanding Options for Relapsed/Refractory HER2+ Metastatic Breast Cancer

Dr Mark Pegram and Dr Julie Gralow discuss treatment options in relapsed/refractory HER2+ metastatic breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME